Literature DB >> 17576036

Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network.

Yurii Chinenov1, Inez Rogatsky.   

Abstract

Toll-like receptors (TLRs) are responsible for the recognition of a variety of microbial pathogens and the initial induction of immune and inflammatory responses. These responses are normally restricted by the adrenally produced glucocorticoid hormones which provide a feedback mechanism to curb unabated inflammation. Glucocorticoids act through a ligand-dependent transcription factor-the glucocorticoid receptor (GR), which engages in a complex network of protein:protein and protein:DNA interactions ultimately activating or repressing target gene transcription. Not surprisingly, multiple mechanisms account for the glucocorticoid interference with TLR signaling including enhanced expression of the natural inhibitors of TLR pathways, direct repression of TLR-activated transcriptional regulators and cross-utilization of cofactors essential for both GR and TLR signaling. Here we discuss recent and unexpected examples of crosstalk between the two transcriptional networks and the emerging role of GR in the regulation of innate immunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17576036     DOI: 10.1016/j.mce.2007.04.014

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  46 in total

Review 1.  Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells.

Authors:  Christopher K Glass; Kaoru Saijo
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

Review 2.  Opposing effects of alcohol on the immune system.

Authors:  Tasha Barr; Christa Helms; Kathleen Grant; Ilhem Messaoudi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-09-14       Impact factor: 5.067

3.  Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.

Authors:  H Schäcke; T M Zollner; W D Döcke; H Rehwinkel; S Jaroch; W Skuballa; R Neuhaus; E May; U Zügel; K Asadullah
Journal:  Br J Pharmacol       Date:  2009-05-06       Impact factor: 8.739

Review 4.  Minireview: latest perspectives on antiinflammatory actions of glucocorticoids.

Authors:  Karolien De Bosscher; Guy Haegeman
Journal:  Mol Endocrinol       Date:  2008-12-18

Review 5.  Glucocorticoid sensitivity in health and disease.

Authors:  Rogier A Quax; Laura Manenschijn; Jan W Koper; Johanna M Hazes; Steven W J Lamberts; Elisabeth F C van Rossum; Richard A Feelders
Journal:  Nat Rev Endocrinol       Date:  2013-10-01       Impact factor: 43.330

Review 6.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

7.  Interferon-alpha: a therapeutic target in systemic lupus erythematosus.

Authors:  Mary K Crow
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

Review 8.  Glucocorticoid receptors: finding the middle ground.

Authors:  Sofie J Desmet; Karolien De Bosscher
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

9.  Delayed addition of glucocorticoids selectively suppresses cytokine production in stimulated human whole blood.

Authors:  Devin L Horton; Daniel G Remick
Journal:  Clin Vaccine Immunol       Date:  2010-05-05

Review 10.  The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore.

Authors:  John M Busillo; John A Cidlowski
Journal:  Trends Endocrinol Metab       Date:  2013-01-08       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.